Order of the President of the General Court of 4 April 2025 – Apellis Europe v Commission

(Case T-18/25 R)

(Interim relief - Medicinal products for human use - Marketing authorisation for Syfovre - Pegcetacoplan - Application for suspension of operation of a measure - No urgency)

(C/2025/2902)

Language of the case: English

Parties

Applicant: Apellis Europe BV (Amsterdam, Netherlands) (represented by: A. Koyuncu, V. Sturla and M. Aretz, lawyers)

Defendant: European Commission (represented by: E. Mathieu and A. Spina, acting as Agents)

Re:

By its application under Articles 278 and 279 TFEU, the applicant seeks the suspension of the operation of Commission Implementing Decision C(2024) 9160 final of 16 December 2024 refusing marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for the medicinal product for human use ‘Syfovre – Pegcetacoplan’.

Operative part of the order

1.	The application for interim measures is dismissed.

2.	The costs are reserved.